FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) met on June 5, 2024, to discuss and make recommendations on the selection of the 2024-2025 Formula for COVID-19 vaccines for use in the United States beginning in the fall of 2024.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/P7wYOIu
No comments:
Post a Comment